Table 1.
Baseline Medical and Demographic Variables by Group Condition (n=135)
| Variable | CBT (n=44) | Relaxation Training (n=49) | Health Education (n=42) | Test Statistic | P |
|---|---|---|---|---|---|
| Age at diagnosis (years) | 54.84 (9.00) | 54.08(12.12) | 55.64(9.00) | F(2,132) = 0.26 | 0.77 |
| Years Education | 16.09 (2.71) | 14.98 (3.30) | 15.46 (3.20) | F(2,128) = 1.47 | 0.23 |
| Household Income (thousands) | 99.58 (70.36) | 82.85 (62.94) | 137.30(166.96) | F(2,114) = 2.50 | 0.09t |
| Race/Ethnicity | χ2(6) = 7.25 | 0.30 | |||
| Non-Hispanic White | 21 (48.8%) | 16 (34.0%) | 19 (45.2%) | ||
| Hispanic | 16 (37.2%) | 25 (53.2%) | 16 (38.1%) | ||
| African-American | 3 (7.0%) | 2 (4.3%) | 6 (14.3%) | ||
| Other | 3 (7.0%) | 4 (8.5%) | 1 (2.4%) | ||
| Partnered at Diagnosis | 31 (72.1%) | 28 (59.6%) | 25 (59.5%) | χ2(2) = 1.97 | 0.37 |
| Stage at Diagnosis | χ2(6) = 1.64 | 0.95 | |||
| Stage 0 | 6 (13.6%) | 4 (8.2%) | 5 (11.9%) | ||
| Stage 1 | 26 (59.1%) | 27 (55.1%) | 24 (57.1%) | ||
| Stage 2 | 10 (22.7%) | 15 (30.6%) | 10 (23.8%) | ||
| Stage 3 | 2 (4.5%) | 3 (6.1%) | 3 (7.1%) | ||
| Positive Nodes | 6 (14.3%) | 14 (29.8%) | 13 (31.7%) | χ2(2) = 4.08 | 0.13 |
| Surgery | χ2(2) = 0.20 | 0.91 | |||
| Lumpectomy | 21 (47.7%) | 24 (49.0%) | 22 (52.4%) | ||
| Mastectomy | 23 (52.3%) | 25 (51.0%) | 20 (47.6%) | ||
| Hormonal Status | |||||
| ER positive | 40 (93.0%) | 45 (97.8%) | 360(94.7%) | χ2(2) = 1.17 | 0.56 |
| PR positive | 34 (82.9%) | 39 (84.8%) | 32 (88.9%) | χ2(2) = 0.57 | 0.75 |
| Days f/ Surgery to T1 | 34.05 (21.14) | 38.45 (24.75) | 37.43 (20.72) | F(2,132) = 0.48 | 0.62 |
| Received Radiation | 23 (52.3%) | 21 (45.7%) | 24 (58.5%) | χ2(2) = 1.45 | 0.49 |
| Received Chemo | 15 (34.1%) | 20 (41.7%) | 13 (31.7%) | χ2(2) = 1.07 | 0.59 |
note. CBT = Cognitive Behavioral Therapy; ER = Estrogen Receptor; PR = Progesterone Receptor.
t
p < 1.0,
*
p < .05,
**
p < .01,
***
p < .001